複製鏈接
請複製以下鏈接發送給好友

劉忠

(暨南大學教授、博士生導師)

鎖定
劉忠,博士、暨南大學生命科學技術學院研究員、博士生導師,基因工程藥物國家工程研究中心副總經理、化妝品研發中心總監,廣東省傑出青年科學基金獲得者、廣東特支計劃科技創新青年拔尖人才、廣州市珠江科技新星、暨南“雙百英才”傑出青年學者。兼任全國質量監管重點產品檢驗方法標準化技術委員會化妝品檢驗方法專業工作組委員,廣東省藥監局天然產物化妝品原料創新技術研究重點實驗室學術委員會主任,廣東省化妝品學會副理事長、常務副秘書長、化妝品原料與天然產物專委會主任,廣東省生物醫學工程學會常務理事、副秘書長,廣東省藥學會核藥學專委會常委,廣州市市場監督管理局食品藥品特種設備安全專家委員會委員, SCI學術期刊Frontiers in PharmacologyFrontiers in Oncology客座副主編。
主要研究方向為:①腫瘤、炎症與自身免疫性疾病靶向創新藥物研究與開發,②功能性化妝品研究與開發。作為項目負責人主持了國家自然科學基金3項,廣東省自然科學基金項目、廣東省科技計劃國際合作項目、廣州市科技計劃重點項目等科研項目13項,與生物醫藥、化妝品企業合作開展項目30餘項。已在SCI國際期刊發表研究論文50餘篇,申請專利13項。研究成果獲中國產學研合作創新與促進獎、廣東省科技進步二等獎。
博士研究生招生方向:生物醫藥
碩士研究生招生方向:生物醫藥、細胞生物學、生物與醫藥(專業學位)
中文名
劉忠
國    籍
中國
民    族
畢業院校
中山大學(博士)
出生地
江西
職    務
教師
職    稱
教授
學    位
博士
學    歷
博士研究生

劉忠人物經歷

2003/9 - 2008/12,中山大學,博士
1999/9 - 2003/6,中山大學,學士
近 5 年獲得的榮譽稱號
  1. 廣東省自然科學傑出青年基金獲得者
  2. 廣東特支計劃科技創新青年拔尖人才
  3. 廣州市珠江科技新星
  4. “暨南雙百英才計劃”傑出青年 [1] 
2009至2023年:暨南大學生命科學技術學院/ 生物醫藥研究院/ 生物醫藥研究開發基地
所在實驗室:基因工程藥物國家工程研究中心、廣東省生物工程藥物重點實驗室、廣東省藥品監督管理局天然產物化妝品原料創新技術研究重點實驗室

劉忠主講課程

  • 《基因工程藥物學》
  • 《細胞信號轉導理論與技術》
  • 《高級生物化學》
  • 《酶工程》

劉忠研究方向

1. 腫瘤、炎症與自身免疫性疾病靶向創新藥物研究與開發。
2. 功能性化妝品研究與開發。

劉忠主要貢獻

劉忠承擔課題

主持的主要科研項目:
1. 國家自然科學基金面上項目(82273979),2023.01-2026.12
2. 國家自然科學基金面上項目(82073864),2021.1-2024.12
3. 國家自然科學基金青年科學基金項目(81001449),2011-2013
4. 廣東省基礎與應用基礎研究基金省企聯合項目(2021A1515220126),2021.11-2024.10.
5. 廣東省自然科學基金傑出青年項目(2017A030306008),2017.5-2021.5,
6. “廣東特支計劃”科技創新青年拔尖人才項目(2016TQ03R849),2017.6-2020.5,
7. 廣東省科技計劃對外科技合作項目(2013B051000061),2014-2016
8. 廣東省自然科學基金面上項目(S2012010008494),2012-2014
9. 廣東省自然科學基金博士啓動項目(10451063201005506),2010-2012
10. 廣州市珠江科技新星項目(201610010108),2016-2019
11. 廣州市科技計劃應用基礎研究重點項目(12C32071601),2011-2013
12. 藥用資源化學與藥物分子工程教育部重點實驗室資助課題(CMEMR2015-B08),2015-2018
13. 天然藥物及仿生藥物國家重點實驗室資助課題(K20120208),2012-2013
14. 暨南大學科研培育與創新基金躍升計劃項目(21615413),2015-2016
15. 暨南大學引進優秀人才科研啓動基金(51209005),2009-2011
入選的人才計劃
1.廣東省自然科學傑出青年基金獲得者(2017)
2.廣東特支計劃青年拔尖人才(2016)
3.廣州市珠江科技新星(2016)
4.“暨南雙百英才計劃”傑出青年學者(2016)
5.廣東省高校“千百十工程”第七批校級培養對象(2012)
6.廣東高校優秀青年創新人才培養計劃(2010)

劉忠發明專利

已授權的專利
[1] 劉忠, 馬冬磊, 揭輝洋, 李滿妹.一種2,6-二取代吡啶-4-硫代甲酰胺的新用途. CN201710643752.3(授權日期2021-01-08)
[2] 劉忠,張卓,王一飛,董長治. 1,2,4-三取代哌嗪化合物在製備抗流感病毒藥物中的用途. 201610351594.X(授權日期2018-10-9)
[3] 葉文才,王磊,劉忠. 一種促進組織修復的新多肽和美洲大蠊總多肽提取物及應用,CN201510768410.5(授權日期2020-06-02)
[4] 葉文才,王磊,劉忠,範春林. 一種促進組織修復的美洲大蠊新多肽及應用,CN201610030509.X(授權日期2020-06-16)
[5] 王一飛,黃雲生,劉忠,吳宗文,宋樹勇,汪聖,利奕成. 一種2-(石榴皮烷-3-氨基)-4-四氫吲唑取代的苯甲酰胺化合物及其應用. ZL201510051928.7. (授權日期2017-02-01)
[6] 孫鴻濤,趙建豪,劉忠,利奕成,張卓,黎程,盧慧勤,黎飛猛. 一種可緩釋生長因子的骨修復粘合劑及其製備方法. 201610929238.1. (授權日期2019-06-07)
[7] 利奕成,孫鴻濤,趙建豪,劉忠,張卓,黎程,黎飛猛,一種抗感染醫用粘合劑及製備方法. 201610928614.5(授權日期2019-06-07)

劉忠主要論文

[1] Ran An, Yu-Qing Li, Yue-Ling Lin, Fang Xu, Man-Mei Li, Zhong Liu*, EZH1/2 as Targets for Cancer Therapy. Cancer Gene Ther. 2023, 30, 221-235.
[2] Wu K#, Liu Z#, Wang W, Zhou F, Cheng Q, Bian Y, Su W, Liu B, Zha J, Zhao J*, Zheng X*, An artificially designed elastin-like recombinant polypeptide improves aging skin. Am J Transl Res. 2022; 14(12): 8562-8571.
[3] Mengting Lin, Yuqing Li, Haiyue Long, Yueling Lin, Zhuo Zhang, Fengyun Zhan, Manmei Li, Chaoxi Wu*, Zhong Liu*, Cell Membrane-Camouflaged DOX-Intercalated Bacterial Glucan nanoparticles for Highly Efficient Cancer Immunochemotherapy. Int J Biol Macromol. 2022, S0141-8130(22):02711-8.
[4] Li-Feng Chen, Wei-Bin Xu, Si Xiong, Jun-Xing Cai, Jing-Jing Zhang, Yao-Lan Li, Man-Mei Li*, Hong Zhang*, Zhong Liu*, PIK-24 Inhibits RSV-Induced Syncytium Formation via Direct Interaction with the p85α Subunit of PI3K. J Virol. 2022, 96(23): e0145322.
[5] Kexin Li#, Jiahua Zou#, Haizhao Yan#, Yuqing Li, Man-Mei Li*, and Zhong Liu*, Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer. Front Chem. 2022,10:1024670.
[6] Lin M, Long H, Liang M, Chu B, Ren Z, Zhou P, Wu C*, Liu Z*, Wang Y*, Antifracture, Antibacterial, and Anti-inflammatory Hydrogels Consisting of Silver-Embedded Curdlan Nanofibrils. ACS Appl Mater Interfaces. 2021, 13(31):36747-36756.
[7] Chen LF, Xu WB, Li YY, Chen NH, Luo D, Song QY, Tang W, Huang ZG, Li YL*, Liu Z*, Li MM*. Inhibitory Effect of PIK-24 on Respiratory Syncytial Virus Entry by Blocking Phosphatidylinositol-3 Kinase Signaling, Antimicrob Agents Chemother. 2020,64(10):e00608-20.
[8] Peng-Chao Zhang#, Xiao Liu#, Man-Mei Li#, Yan-Yan Ma, Hong-Tao Sun, Xu-Yan Tian, Yan Wang, Min Liu, Liang-Shun Fu, Yi-Fei Wang, Hong-Yuan Chen*, Zhong Liu*, AT-533, a novel Hsp90 inhibitor, inhibits breast cancer growth and HIF-1α/VEGF/VEGFR-2-mediated angiogenesis in vitro and in vivo, Biochem Pharmacol. 2020, 172:113771.
[9] P. Zhang, H. Jie, J. Liu, Xin-Yue Zhang, W. Zhang, M. Liu, Yan Wang, Yi-Fei wang, W. Huang*,Z. Liu*, Studies on Substituted Thienopyridine Carbonitriles as Src Inhibitors Using a Comprehensive In Silico Method, Indian J Pharm Sci. 2020;82(2):270-281.
[10] Liang-Shun Fu, Hong-Hong Qiu, Min Liu, Liu-Bing Hu, Yan Wang, Peng-Chao Zhang, Man-Mei Li, Yi-Fei Wang*, Zhong Liu*, SNX-2112, an Hsp90 inhibitor, suppresses cervical cancer cells proliferation, migration, and invasion by inhibiting the Akt/mTOR signaling pathway, Med Chem Res. 2020(29):942-953.
[11] Fang Z#, Wang X#, Sun Y, Fan R, Liu Z*, Guo R*, Xie D*, Sgc8 aptamer targeted glutathione-responsive nanoassemblies containing Ara-C prodrug for the treatment of acute lymphoblastic leukemia, Nanoscale. 2019,11(47):23000-23012.
[12] Hu LB#, Huang WH#, Ding Y#, Liu M, Wang M, Wang Y, Zhang W, Li YL, Ye WC, Li MM*, Liu Z*, PHMH, a diarylheptanoid from Alpinia officinarum attenuates VEGF-induced angiogenesis via inhibition of the VEGFR-2 signaling pathway. Food Funct. 2019. 10: 2605-2617.
[13] Hu LB#, Wang Y#, Chen Z, Fu, LS, Wang S, Zhang XY, Zhang PC, Lu XP, Jie HY, Li MM*, Wang YF*, Liu Z*, Hsp90 Inhibitor SNX-2112 Enhances TRAIL-Induced Apoptosis of Human Cervical Cancer Cells via the ROS-Mediated JNK-p53-Autophagy-DR5 Pathway. Oxid Med Cell Longev. 2019, 2019: 9675450.
[14] Wu Y#, Zhang XY#, Li HQ, Deng PF, Li HR, He TQ, Rong JH, Zhao JH*, Liu Z*, A core/shellstabilized polysaccharide-based nanoparticle with intracellular environment-sensitive drug delivery for breast cancer therapy. J Mater Chem B. 2018, 6:6646-6659.
[15] Wang Y#, Zhou PJ#, Qin SR#, Xu DD, Liu YK, Fu WY, Ruan BB, Zhang L, Zhang Y, Wang XY, Pan YW, Wang S, Yan HZ, Qin JH, Wang XY, Liu QY, Du ZY*, Liu Z*, Wang YF*. The curcumin analogs 2-pyridyl cyclohexanone induces apoptosis via inhibition of the JAK2-STAT3 pathway in human esophageal squamous cell carcinoma cells. Front Pharmacol. 2018, 9:820.
[16] Liu Q#, Xiao XH#, Hu LB, Jie HY, Wang Y, Ye WC*, Li MM*, Liu Z*. Anhuienoside C ameliorates collagen-induced arthritis through inhibition of MAPK and NF-κB signaling pathways. Front Pharmacol. 2017, 8:299.
[17] Zhang L#, Wang XY#, Zhou PJ#, He Z, Yan HZ, Xu DD, Wang Y, Fu WY, Ruan BB, Wang S, Chen HX, Liu QY, Zhang YX, Liu Z*, Wang YF*. Use of immune modulation by human adipose-derived mesenchymal stem cells to treat experimental arthritis in mice. Am J Transl Res. 2017, 9(5): 2595-2607.
[18] Xie ZZ#, Li MM#, Deng PF, Wang S, Wang L, Lu XP, Hu LB, Chen Z, Jie HY, Wang YF, Liu XX*,Liu Z*. Paris saponin-induced autophagy promotes breast cancer cell apoptosis via the Akt/mTOR signaling pathway. Chem-Biol Interact. 2017, 264:1-9.
[19] Liu Z#, Liu G#, Zhang GL#, Li J, He YQ, Zhang SS, Wang Y, He WY, Cheng GH, Yang X, Xu J, Wang J*, Binding of human recombinant mutant soluble ectodomain of FGFR2IIIc to c subtype of FGFRs: implications for anticancer activity. Oncotarget, 2016, 7(42):68473-68488.
[20] Shao FY#, Wang S#, Li, HY#, Chen WB, Wang GC, Ma DL, Wong NS, Xiao H, Liu QY, Zhou GX, Li YL, Li MM*, Wang YF*, Liu Z*. EM23, a natural sesquiterpene lactone, targets thioredoxin reductase to activate JNK and cell death pathways in human cervical cancer cells. Oncotarget, 2016, 7(6):6790-6808.
[21] Li H#, Li M#, Wang G, Shao F, Chen W, Xia C, Wang S, Li Y*, Zhou G* and Liu Z*. EM23, a natural sesquiterpene lactone from Elephantopus mollis, induces apoptosis in human myeloid leukemia cells through thioredoxin- and reactive oxygen species-mediated signaling pathways,Front Pharmacol, 2016, 7:77.
[22] Xu DD#, Zhou PJ#, Wang Y#, Zhang Y, Zhang R, Zhang L, Chen SH, Ruan BB, Xu HP, Fu WY, Hu CZ, Tian L, Qin JH, Wang S, Wang X, Liu QY, Ren Z, Gu XQ, Li YH, Liu Z*, Wang YF*. miR-150 suppresses the proliferation and tumorigenicity of leukemia stem cells by targeting the Nanog signaling pathway, Front Pharmacol, 2016, 7:439.
[23] Fan Z#, Sun ZH#, Liu Z#, Chen YC, Liu HX, Li HH, Zhang WM. Dichotocejpins A-C: New Diketopiperazines from a Deep-Sea-Derived Fungus Dichotomomyces cejpii FS110. Mar Drugs. 2016, 14(9):164.
[24] Shao FY#, Du ZY#, Ma DL, Chen WB, Fu WY, Ruan BB, Rui W, Zhang JX, Wang S, Wong NS, Xiao H, Li MM, Liu X, Liu QY, Zhou XD, Yan HZ, Wang YF, Chen CY, Liu Z*, Chen HY*. B5, a thioredoxin reductase inhibitor, induces apoptosis in human cervical cancer cells by suppressing the thioredoxin system, disrupting mitochondrion-dependent pathways and triggering autophagy.Oncotarget, 2015, 6(31):30939-30956.
[25] Xu JJ#, Liu Z#, Tang W#, Wang GC, Chung HY, Liu QY, Zhuang L, Li MM*, Li YL*. Tangeretin from citrus reticulate inhibits respiratory syncytial virus replication and associated inflammation in vivo. J Agric Food Chem. 2015, 63 (43):9520-9527.
[26] Xu GG, Liu X, Lin YQ, He GS, Wang WJ, Xiong W, Luo HY, Liu Z*, Zhao JH*. Thermal hydrolysis of poly(L-lactic acid) films and cytotoxicity of water-soluble degradation products. J Appl Polym Sci. 2015, 132(25).
[27] Qiu XX#, Zhong MG#, Xiang YF, Qu C, Pei Y, Zhang YJ, Yang CR, Gasteiger J, Xu J, Liu Z*, Wang YF*. Self-Organizing Maps for the Classification of Gallic Acylate Polyphenols as HSV-1 Inhibitors. Med Chem. 2014, 10, 388-401.
[28] Wang R#, Shao FY#, Liu Z*, Zhang JX, Wang SX, Liu JY, Liu H, Chen HY, Liu KS, Xia M, Wang YF*. The Hsp90 inhibitor SNX-2112, induces apoptosis in multidrug resistant K562/ADR cells through suppression of Akt/NF-κB and disruption of mitochondria-dependent pathways. Chem-Biol Interact. 2013, 205(1): 1-10.
[29] Zhong MG#, Xiang YF#, Qiu XX, Liu Z*, Kitazato K*, Wang YF*. Natural products as a source of anti-herpes simplex virus agents, RSC Adv. 2013, 3(2): 313-328.
[30] Zhang WJ#, Liu Z#, Li SM, Lu YZ, Chen YC, Zhang HB, Zhang GT, Zhu YG, Zhang GY, Zhang WM, Liu JS, Zhang CS*. Fluostatins I-K from the South China Sea-DerivedMicromonosporarosaria SCSIO N160. J Nat Prod. 2012, 75 (11): 1937-1943.
[31] Liu JY#, Liu Z#, Wang DM, Li MM, Wang SX, Wang R, Chen JP, Wang YF*, Yang DP*. Induction of apoptosis in K562 cells by dicyclohexylammonium salt of hyperforin through a mitochondrial-related pathway. Chem-Biol Interact. 2011, 190(2-3): 91-101.
[32] Wang SX#, Ju HQ#, Liu KS, Zhang JX, Wang X, Xiang YF, Wang R, Liu JY, Liu QY, Xia M, Xing GW, Liu Z*, Wang YF*. SNX -2112, a novel Hsp90 inhibitor, induces G2/M cell cycle arrest and apoptosis in MCF-7 cells. Biosci Biotech Bioch. 2011, 75(8): 1540-1545.
[33] Liu Z#, Huang SL#, Li MM, Huang ZS, Lee KS*, Gu LQ*. Inhibition of thioredoxin reductase by mansonone F analogues: implications for anticancer activity. Chem-Biol Interact. 2009, 177(1): 48-57.
[34] Liu Z, Du ZY, Huang ZS, Lee KS*, Gu LQ*. Inhibition of thioredoxinreductase by curcumin analogs. Biosci Biotech Bioch. 2008, 72(8): 2214-2218.
[35] Qiu X#, Liu Z#, Shao WY, Liu X, Jing DP, Yu YJ, An LK, Huang SL, Bu XZ*, Huang ZS, Gu LQ. Synthesis and evaluation of curcumin analogues as potential thioredoxinreductase inhibitors.Bioorg Med Chem. 2008, 16(17): 8035-8041.
[36] Wen L, Liang L, Yang X, Liu Z, Li B, Chen Q. Multiband and Ultrahigh Figure-of-Merit Nanoplasmonic Sensing with Direct Electrical Readout in Au-Si Nanojunctions. ACS Nano. 2019, 13(6):6963-6972.
[37] Li H, Zhang X, Lin X, Zhuang S, Wu Y, Liu Z, Rong J, Zhao J. CaCO3 nanoparticles pH-sensitively induce blood coagulation as a potential strategy for starving tumor therapy. J Mater Chem B. 2020:(6):1223-1234.
[38] Chen LF, Zhong YL, Luo D, Liu Z, Tang W, Cheng W, Xiong S, Li YL*, Li MM*. Antiviral activity of ethanol extract of Lophatherum gracile against respiratory syncytial virus infection. J Ethnopharmacol. 2019; 242:111575.
[39] Zhuang L, Chen LF, Zhang YB, Liu Z, Xiao XH, Tang W, Wang GC, Song WJ, Li YL*, Li MM*. Watsonianone A from Rhodomyrtus tomentosa Fruit Attenuates Respiratory-Syncytial-Virus-Induced Inflammation In Vitro.J. Agric. Food Chem. 2017,65(17):3481-3489.
[40] Huang P, Chen A, He W, Li Z, Zhang G, Liu Z, Liu G, Liu X, He S, Xiao G, Huang F, Stenvang J, Brünner N, Hong A, Wang J. BMP-2 induces EMT and breast cancer stemness through Rb and CD44. Cell Death Discov. 2017,3:17039.
[41] Yuan N, Xu L, Zhang L, Ye H, Zhao J, Liu Z, Rong J. Superior hybrid hydrogels of polyacrylamide enhanced by bacterial cellulose nanofiber clusters. Mater Sci Eng C. 2016,67:221-30.
[42] Zhang Y, Zhou SY, Yan HZ, Xu DD, Chen HX, Wang XY, Wang X, Liu YT, Zhang L, Wang S, Zhou PJ, Fu WY, Ruan BB, Ma DL, Wang Y, Liu QY, Ren Z, Liu Z, Zhang R, Wang YF. miR-203 inhibits proliferation and self-renewal of leukemia stem cells by targeting survivin and Bmi-1. Sci Rep. 2016,6:19995.
[43] Wang WJ, Wang L, Liu Z, Jiang RW, Liu ZW, Li MM, Zhang QW, Dai Y, Li YL, Zhang XQ, Ye WC. Antiviral benzofurans from Eupatorium chinense. Phytochemistry. 2016, 122:238-45.
[44] Lu D, Dong D, Liu Z, Wang Y, Wu B. Metabolism elucidation of BJ-B11 (a heat shock protein 90 inhibitor) by human liver microsomes:identification of main contributing enzymes. Expert Opin Drug Metab Toxicol. 2015,11(7):1029-40.
[45] Liu Q, Zhu XZ, Feng RB, Liu Z, Wang GY, Guan XF, Ou GM, Li YL, Wang Y*, Li MM*, Ye WC*, Crude triterpenoid saponins from Anemone laccida (Di Wu) exert anti-arthritic efects on type II collagen-induced arthritis in rats. Chin Med. 2015, 10:20.
[46] Feng RB, Fan CL, Liu Q, Liu Z, Zhang W, Li YL, Tang W, Wang Y*, Li MM*, Ye WC*. Crude triterpenoid saponins from Ilex latifolia (Da Ye Dong Qing) ameliorate lipid accumulation by inhibiting SREBP expression via activation of AMPK in a non‑alcoholic fatty liver disease model.Chin Med. 2015, 10:23.
[47] Chen H, Liu X, Clayman ES, Shao F, Xiao M, Tian X, Fu W, Zhang C, Ruan B, Zhou P, Liu Z, Wang Y, Rui W. Synthesis and evaluation of a CBZ-AAN-Dox prodrug and its in vitro effects on SiHa cervical cancer cells under hypoxic conditions. Chem Biol Drug Des. 2015:86(4):589-98.
[48] Tian YX, Shen YD, Zhang XZ, Ye LB, Li ZH, Liu Z, Zhang JJ, Wu SG. Design Some New Type-I c-met Inhibitors Based on Molecular Docking and Topomer CoMFA Research. Mol Inform, 2014, 33(8):536-543.
[49] Zhang W, Ma L, Li S, Liu Z, Chen Y, Zhang H, Zhang G, Zhang Q, Tian X, Yuan C, Zhang S, Zhang W, Zhang C. Indimicins A-E, Bisindole Alkaloids from the Deep-Sea-Derived Streptomyces sp. SCSIO 03032. J Nat Prod. 2014, 77:1887-1892.
[50] Liu C, Liu Z, Li M, Li X, Wong YS, Ngai SM, Zheng W*, Zhang Y, Chen T*. Enhancement of auranofin-induced apoptosis in MCF-7 human breast cells by selenocystine, a synergistic inhibitor of thioredoxin reductase. PLoS One. 2013, 8(1):e53945
[51] Yang XW, Peng K, Liu Z, Zhang GY, Li J, Wang N*, Steinmetz A, Liu Y*. Strepsesquitriol, a Rearranged Zizaane-Type Sesquiterpenoid from the Deep-Sea-Derived Actinomycete Streptomyces sp. SCSIO 10355. J Nat Prod. 2013, 76 (12),:2360-2363.
[52] Qin J*, Lan W, Liu Z, Huang J, Tang H, Wang H*. Synthesis and biological evaluation of 1, 3-dihydroxyxanthone mannich base derivatives as anticholinesterase agents. Chem Cent J. 2013, 7(1):78.
[53] Wu ZC, Li S, Nam SJ, Liu Z, Zhang C*. Nocardiamides A and B, two cyclohexapeptides from the marine-derived actinomycete nocardiopsis sp. CNX037. J Nat Prod. 2013, 76 (4):694-701.
[54] Wu X, Lan P, Liu Z, Ruan ZX, Wang H, Wang GC, Ye WC, Li YL*. 3D-QSAR studies of natural steroidal saponins as anticancer agents in human nasopharyngeal carcinoma epithelial cells.Lett Drug Des Discov. 2013, 10(3):245-252.
[55] Zhang W, Liu Z, Li S, Yang T, Zhang Q, Ma L, Tian X, Zhang H, Huang C, Zhang S, Ju J, Shen Y, Zhang C*. Spiroindimicins A-D:new bisindole alkaloids from a deep-sea-derived actinomycete.Org Lett, 2012, 14 (13), 3364-3367.
[56] He F, Liu Z, Yang J, Fu P, Peng J, Zhu WM*, Qi SH*. A novel antifouling alkaloid from halotolerant fungus Penicillium sp. OUCMDZ-776, Tetrahedron Lett. 2012, 53(18):2280-2283.
[57] Li MM, Wu S, Liu Z, Zhang W, Xu J, Wang Y, Liu JS, Zhang DM, Tian HY, Li YL*, Ye WC*. Arenobufagin, a bufadienolide compound from toad venom, inhibits VEGF-mediated angiogenesis through suppression of VEGFR-2 signaling pathway. Biochem Pharmacol. 2012, 83(9):1251-1260.
[58] Liu KS, Ding WC, Wang SX, Liu Z, Xing GW, Wang Y, Wang YF*. The heat shock protein 90 inhibitor SNX-2112 inhibits B16 melanoma cell growth in vitro and in vivo. Oncol Rep. 2012, 27(6):1904-1910.
[59] Liu KS, Liu H, Qi JH, Liu QY, Liu Z, Xia M, Xing GW, Wang SX*, Wang YF*. SNX-2112, an Hsp90 inhibitor, induces apoptosis and autophagy via degradation of Hsp90 client proteins in human melanoma A-375 cells. Cancer Lett. 2012, 318(2):66-74.
[60] Zhang XQ, Xu FF, Wang L, Huang MY, Liu Z, Zhang DM, Wang GC, Li YL, Ye WC*, Two pairs of new diastereoisomeric flavonolignans from the seeds of Hovenia acerba. Phytochem Lett. 2012, 5(2):292-296.
[61] Liu XT, Schwan WR, Volk TJ, Rott M, Liu M, Huang P, Liu Z, Wang Y, Zitomer NC, Sleger C, Hartsel S, Monte A*, Zhang L*. Antibacterial Spirobisnaphthalenes from the North American Cup Fungus Urnula craterium. J Nat Prod. 2012, 75(9):1534-1538.
[62] Liu KS, Zhang Y, Ding WC, Wang SX, Xiang YF, Yang P, Chen ZP, Zheng K, Liu Z, Xia M, Wang YF*. The selective Hsp90 inhibitor BJ-B11 exhibits potent antitumor activity via induction of cell cycle arrest, apoptosis and autophagy in Eca-109 human esophageal squamous carcinoma cells. Int J Oncol. 2012, 41:2276-2284.
[63] Zhai QQ, Gong GQ, Liu Z, Luo Y, Xia M, Xing GW, You XF, Wang YF*. Preclinical pharmacokinetic analysis of SNX-2112, a novel Hsp90 inhibitor, in rats. Biomed Pharmacother. 2011, 65(2):132-136.
[64] Sun F, Liu JY, He F, Liu Z, Wang R, Wang DM, Wang YF*, Yang DP*. In-vitro antitumor activity evaluation of hyperforin derivatives. J Asian Nat Prod Res. 2011, 13(8):688-699.
[65] Ju HQ, Wang SX, Xiang YF, Liu Z, Liu JY, Chen ZP, Zeng FL, Xia M, Liu ZH, Xing GW*, Wang SY*, Wang YF*. BJ-B11, a novel Hsp90 inhibitor, induces apoptosis in human chronic myeloid leukemia K562 cells through the mitochondria-dependent pathway. Eur J Pharmacol. 2011, 666:26-34.
[66] Shao M, Wang Y, Liu Z, Zhang DM, Cao HH, Jiang RW, Fan CL, Zhang XQ, Chen HR, Yao XS, Ye WC*. Psiguadials A and B, two novel meroterpenoids with unusual skeletons from the leaves of Psidium guajava. Org Lett. 2010, 12(21):5040-5043.
[67] Zhou GX*, Mo SY, He HX, Shi JG, Ye WC, Liu Z. Jiang RW*, Molecular structure and tautomerization of the 1:1 complex of luteoskyrin and rugulosin J Mol Struct. 2010, 979(1):86-91.
[68] Tian HY, Wang L, Zhang XQ, Wang Y, Zhang DM, Jiang RW, Liu Z, Liu JS, Li YL, Ye WC*. Bufogargarizins A and B two novel 19-norbufadienolides with unprecedented skeletons from the venom of bufo bufo gargarizans. Chem Eur J. 2010, 16(36):10989-10993.
[69] Zhai QQ, Gong GQ, Luo Y, Wang QD, Xia M, Xing GW, Li YC, Jiang JH, Liu Z, Liu QY, Wang YF*. Determination of SNX-2112, a selective Hsp90 inhibitor in plasma samples by high-performance liquid chromatography and its application to pharmacokinetics in rats. J Pharm Biomed Anal. 2010, 53(4):1048-1052.
[70] Du ZY, Bao YD, Liu Z, Qiao W, Ma L, Huang ZS*, Gu LQ*, Chan ASC. Curcumin analogs as potent aldose reductase inhibitors. Arch Pharm (Weinheim). 2006, 339(3):123-128.

劉忠社會職務

2019.10.14-至今:SCI期刊Frontiers in Pharmacology、 Frontiers in Oncology客座副主編
2021.-至今:廣東省藥理學會抗炎藥理專委會常委
2020.-至今:廣東省藥學會核藥學專委會常委
2020.6-至今:全國質量監管重點產品檢驗方法標準化技術委員會化妝品檢驗方法專業工作組委員
2020.3-至今:廣州市市場監督管理局食品藥品特種設備安全專家委員會委員
2016.11-至今:廣東省化妝品學會副理事長、常務副秘書長、化妝品原料與天然產物專委會主任委員
2016.9-2020.9: 廣東省生物醫學工程學會常務理事、副秘書長
2020.9-至今:廣東省生物醫學工程學會常務理事、副秘書長
2016.3-至今:暨南大學高水平大學建設“生物學組團”特聘研究員
2015.1-2016.9:廣東省生物醫學工程學會理事、副秘書長
2015.4-至今:生命科學技術學院工會青工委主任
2014.10-至今:廣東省藥學會製藥工程專業委員會藥食同源專題組副組長
2014.10-至今:廣東省藥學會製藥工程專業委員中藥提取物專題組秘書
2010年-至今:廣東省生物醫學工程學會青年工作委員會委員
參考資料